Sichuan, China

Ke Chen

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:


Years Active: 2019-2024

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: **Innovative Contributions of Inventor Ke Chen**

Introduction

Ke Chen is an accomplished inventor based in Sichuan, China, known for his significant contributions to the field of pharmaceutical innovations. With a total of four patents to his name, his work primarily focuses on developing compounds that target various cancer types, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among Ke Chen's latest inventions are two notable patents involving a BRD4 inhibitor and its application in treating cancer. The first patent details a compound designed to effectively inhibit the proliferation of human prostate cancer cells (CWR22RV1) and breast cancer cells. Notably, when used in combination with the androgen receptor inhibitor HC-1119, the compound enhances the efficacy of treatment for prostate cancer, demonstrating greater inhibitory effects as its concentration increases. This particular compound can be utilized independently or alongside other agents, making it a versatile option for developing antineoplastic agents with improved therapeutic outcomes. The second patent focuses on the compound represented in formula I, highlighting its broad application for combatting tumors and autoimmune conditions, as well as its potential as an anti-prostate cancer drug.

Career Highlights

Ke Chen has had a distinguished career, contributing to significant advancements in pharmaceutical research. His experience includes working at Hinova Pharmaceuticals Inc., where he played a crucial role in developing innovative therapeutic compounds. Additionally, he has been associated with the Chinese Academy of Sciences, further enhancing his expertise in the field.

Collaborations

Throughout his career, Ke Chen has collaborated with talented professionals, including Lei Fan and Kexin Xu. These partnerships have facilitated knowledge exchange and fostered innovation, allowing them to make strides in cancer research and drug development.

Conclusion

Ke Chen's work stands as a testament to the power of innovation in the medical field. With multiple patents addressing critical challenges in cancer treatment, his contributions are paving the way for more effective therapies, ultimately benefiting patients and the broader medical community. His dedication to research and collaboration continues to influence advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…